Expression Profile of Human Cytomegalovirus UL111A cmvIL-10 and LAcmvIL-10 Transcripts in Primary Cells and Cells from Renal Transplant Recipients
Human cytomegalovirus (HCMV) is a high-risk pathogen in immunocompromised individuals, especially in transplant recipients.HCMV viremia must be monitored, and frequently, patients are treated with antiviral agents.HCMV has a variety of strategies to modulate host antiviral responses, and one important player is a viral homolog of the cellular inter